FDA inspection
Zhejiang Guobang Pharmaceutical Co., Ltd: FDA inspection ending Jul 13, 2018
FDA inspection 1067561 · No Action Indicated (NAI) · Shangyu
Key facts
| Inspection ID | 1067561 |
|---|---|
| Firm | Zhejiang Guobang Pharmaceutical Co., Ltd |
| FEI number | 3008617115 |
| Address | No 6 Weiwu Road Hangzhou, Industrial Zone |
| City | Shangyu |
| Fiscal year | 2018 |
| Inspection end date | Jul 13, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data